Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Glee Star is fighting to Cure FSH Muscular Dystrophy as National Walk & Roll Ambassador

Actor Max Adler's family experience with the devastating muscle wasting disease inspires him to champion research and awareness


News provided by

FSHD Society

Aug 25, 2020, 08:00 ET

Share this article

Share toX

Share this article

Share toX

Max Adler is national ambassador for the Walk & Roll to Cure FSHD
Max Adler is national ambassador for the Walk & Roll to Cure FSHD
Youtube
Youtube

LEXINGTON, Mass., Aug. 25, 2020 /PRNewswire-PRWeb/ -- The FSHD Society, a 501c3 nonprofit patient advocacy organization, announced today that Max Adler, an actor best known for his roles on the hit series "Glee," available for streaming on Netflix, and "Switched at Birth", is serving as this year's national ambassador for the organization's signature fundraiser, Walk & Roll to Cure FSHD, taking place September 12. There are currently no treatments available to people with FSHD and with Max Adler's help the FSHD Society is hoping to raise $500,000 to be put towards research and drug development with the goal of having an approved therapy by 2025.

While Covid-19 forced the FSHD Society to shift their annual Walk & Roll to a virtual format, Adler enthusiastically accepted the challenge of raising awareness and funds despite difficult landscape because of his personal connection to FSHD, one of the most prevalent forms of Muscular Dystrophy. FSHD attacks the muscles in many parts of the body, often affecting people's ability to smile, lift objects, and walk.

“I watched my Mom and Grandma struggle with this disease, and I don’t want that to happen to anyone, anywhere, ever again,” Max Adler said.

Post this

"I watched my Mom and Grandma struggle with this disease, and I don't want that to happen to anyone, anywhere, ever again," said Adler. "My grandmother, for example, had a motorized scooter attached to the back of her car, and every time she parked, I remember having to assist her with being able to get out of the driver's seat, which was no easy task, and helping her walk ever so slowly to the back of the car to get the scooter, holding onto the car so she wouldn't fall. The hot, hot, burning car in the Arizona sun. It was agonizing to see."

"My mother was also diagnosed with FSHD, as the disease can be passed genetically," Adler explains. "Simple things like walking from her bedroom to the living room required a rolling stool for her to lean on because she could no longer walk upright. Other things that usually don't require much effort or thought such as grabbing a coffee mug from a shelf above your head became the most arduous challenges for her, bringing tears to her eyes, which of course then brought them to mine."

"The money we're raising by participating in this Walk & Roll is supporting programs and funding research that will directly impact patients and their families living with FSHD," Adler said. "Every dollar raised brings us closer to a treatment…I hear it could be as soon as 2025."

As national ambassador, Adler is inviting his fans to join him in fundraising for FSHD research or by raising awareness through posting to social media with #curefshd #nationalwalkroll. Walk & Roll participants will have an opportunity to win a special "Moment with Max." Winners in each category below will be invited to a live Facebook event on September 12 to chat, one-on-one, with Adler.

  • Highest Fundraiser – the walker/roller who raises the most money on their personal page (whether participating as an individual or on a team);
  • Captain of the Largest Team – the team captain that recruits the most active team members and has the highest number of their team members raise any amount;
  • Social Butterfly – largest social footprint, tracked by using #NationalFSHDWalkRoll, #CureFSHD, and a local event hashtag.

Supporters across the U.S. (and beyond) can register for the FSHD Society National Virtual Walk & Roll by visiting FSHDSociety.org/walk-Roll. Supporters can also tune in on the FSHD Society Facebook Live telethon on September 12 to watch special appearances with Max Adler, patients and leading researchers.

About Max Adler
Actor Max Adler is best known for his work on the multiple award-winning hit shows "Glee" and "Switched at Birth," appearing as the closeted slushy throwing football bully Dave Karofsky, and class clown accused of sexual assault Tank, respectively. Adler can now be seen in the hit Sundance Festival film Mope, currently streaming on iTunes and Amazon, as well as Aaron Sorkin's The Trial of the Chicago 7, being released on Netflix on October 16, 2020, on which he also serves as co-executive producer. Adler is heavily involved with activism and charity organizations such as the It Gets Better Project in which his video has garnered over a half a million views on YouTube, The Trevor Project, GLAAD, and the FSHD Society. Witnessing his late mother and grandmother struggle with FSH Muscular Dystrophy sent Adler on a path to find a treatment and cure so no other family will ever have to battle this disease and struggle with it. Adler currently resides in Los Angeles with his wife, Jennifer, and newborn son, Dylan.

About the FSHD Society (http://www.fshdsociety.org)
The FSHD Society is the world's largest research-focused patient organization for facioscapulohumeral muscular dystrophy (FSHD), one of the most prevalent forms of muscular dystrophy. The Society has catalyzed major advancements and is accelerating the development of treatments and a cure to end the pain, disability, and suffering endured by one million people worldwide who live with FSHD. The FSHD Society has transformed the landscape for FSHD research and is committed to making sure that no one faces this disease alone. The Society offers a community of support, news, and information through its website at https://www.fshdsociety.org.

SOURCE FSHD Society

Related Links

http://www.fshdsociety.org

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.